書籍詳細

総論

P.8 掲載の参考文献

• 1) Grau AI, Weimar C, Buggle F, et al:Risk factors, outcome, and treatment in subtypes of ischemic stroke;the German Stroke Data Bank. Stroke 32:2559-2566, 2001

• 2) Kolominsky-Rabas PL, Weber M, Gefeller O, et al:Epidemiology of ischemic stroke subtypes according to TOAST criteria:incidence, recurrence, and long-term survival in ischemic stroke subtypes;a population-based study. Stroke 32:2735-2740, 2001
  pubmed

• 3) National Institute of Neurological Disorders and Stroke Ad Hoc Committee:Classfication of cerebrovascular diseases III. Stroke 21:637-676, 1990

• 4) Adams HP Jr, Bendixen BH, Kappelle LJ, et al:Classification of subtype of acute ischemic stroke;definitions for use in a multicenter clinical trial. Stroke 24:35-41, 1993

• 5) Gordon DL, Bendixen BH, Adams HP Jr, et al:Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke;implications for clinical trials. Neurology 43:1021-1027, 1993
  pubmed

• 6) Bogousslavsky J, Regli F:Unilateral watershed cerebral infarcts. Neurology 36:373-377, 1986
  pubmed

• 7) Bogousslavsky J, Regli F:Borderzone infarctions distal to internal carotid artery occlusion:Prognostic implications. Ann Neurol 20:346-350, 1986
  pubmed

• 8) Graeber MC, Jordan JE, Mishra SK, et al:Watershed infarction on computed tomographic scan. An unreliable sign of hemodynamic stroke. Arch Neurol 49:311-313, 1992
  pubmed

• 9) Chimowitz MI, Poole RM, Starling MR, et al:Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke 28:941-945, 1997.
  pubmed

• 10) Fisher CM:Lacunes;small, deep, cerebral infarcts. Neurology 15:774-784, 1965
  pubmed

• 11) Ikeda K et al:Increased prevalence of vascular dementia in Japan;a community-based epidemiological study. Neurology 57:839-844, 2001

• 12) Henon H, Durieu I, Guerouaou D, et al:Poststroke dementia:incidence and relationship to prestroke cognitive decline. Neurology 57:1216-1222, 2001
  pubmed

• 13) Amarenco P, Cohen A, Tzourio C, et al:Atherosclerotic disease of the aonic arch and the risk of ischemic stroke. N Engl J Med 331:14741479, 1994

• 14) Amarenco P, Duyckaerts C, Tzourio O, et al:The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 326:221-225, 1992

• 15) Toyoda K, Yasaka M, Nagata S, et al:Aortogenic embolic stroke;transesophageal echocardiographic approach. Stroke 23:1056-1061, 1992
  pubmed

• 16) 山口武典:わが国の脳卒中診療の現状と21世紀の展望. 脳卒中 23:261-268, 2001
  Medical*Online

• 17) Tanizaki Y, Kiyohara Y, Kato I, et al:Incidence and risk factors for subtypes of cerebral infarction in a general population;the Hisayama Study. Stroke 31:2616-2622, 2000

• 18) 輪田順一ら:脳梗塞例の長期予後と再発作. 久山町18年間の追跡調査. 脳卒中 5:124-130, 1983

• 19) Hankey GJ, Jamrozik K, Broadhurst RJ, et al:Long-term risk of first recurrence stroke in the Perth Community Stroke Study. Stroke 29:2491-2500, 1998
  pubmed

• 20) Westling B, Norrving B, Thomgren M:Survival following stroke. A prospective populatio-based study of 438 hospitalized cases with prediction according to subtype, severity and age. Acta Neurol Scand 81:457-463, 1990

• 21) Sacco RL, Foulkes MA, Mohr JP, et al:Determinants of early recurrence of cerebral infarction;the Stroke Data Bank. Stroke 20:983-989, 1989
  pubmed

• 22) Moroney JT, Bagiella E, Paik MC, et al:Risk factors for early recurrence after ischemic stroke;the role of stroke syndrome and subtype. Stroke 29:2118-2124, 1998
  pubmed

• 23) Sacco RL, Shi T, Zamanillo MC, et al:Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community;the Northem Mahattan Stroke Study. Neurology 44:626634, 1994

• 24) Petty GW, Brown RD Jr, Whisnant JP, et al:Ischemic stroke subtypes;a population-based study of functional outcome, survival, and recurrence. Stroke 31:1062-1068, 2000
  pubmed

• 25) Yamamoto H, Bogousslavsky J:Mechanisms of second and further strokes. J Neurol Neurosurg Psychiatry 64:771-776, 1998
  pubmed

• 26) Sacco RL, Wolf PA, Kannel WB, et al:Survival and recurrence following stroke;the Framingham study. Stroke 13:290295, 1982

• 27) Sacco RL, Wolf PA, Gorelick PB:Risk factors and their management for stroke prevention;outlook for 1999 and beyond. Neurology 53 (Supp 4):S15-S24, 1999

• 28) Jorgensen HS, Kammersgaard LP, Nakayama H, et al:Treatment and rehabilitation on a stroke unit improves 5-year survival;a community-based study. Stroke 30:930-933, 1999
  pubmed

• 29) Stroke Unit Trialists Collaboration. Collaborative systematic overview of the randomized trials of organized inpatient (stroke unit) care after stroke. BMJ 314:1151-1159, 1997

P.15 掲載の参考文献

• 1) 橋本洋一郎, 寺崎修司, 米原敏郎ら:脳梗塞診療のガイドライン. 脳梗塞の診断と治療-ブレインアタック時代の新たな展開-(内野 誠監修, 橋本洋一郎編著), pp1-9, 診療新社, 大阪, 1999

• 2) National Institue of Neurological Disorders and Stroke:Classification of cerebrovascular diseases III. Stroke 21:637-676, 1990

• 3) Cerebral Embolism Task Force:Cardiogenic brain embolism. Arch Neurol 43:71-84, 1986
  pubmed

• 4) Bock BF:Response system for patients presenting with acute stroke. In:Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke (ed by Marler JR, Jones PW, Emr M), National Institute of Neurological Disorders and Stroke, National Institute of Health, No. 97-4239, pp55-56, NIH Publication, Bethesda, 1997

• 5) 橋本洋一郎, 平野照之:脳梗塞のearly CT sign. 医学のあゆみ 191:663-669, 1999
  Medical*Online

• 6) Moulin T, Cattin F, Crepin-Leblond T, et al:Early CT sign in acute middle cerebral artery infarction:predictive value for subsequent infarct locations and outcome. Neurology 47:366-375, 1996
  pubmed

• 7) von Kummer R, Meyding-Lamade U, Forsting M, et al:Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR 15:9-15, 1994
  pubmed

• 8) Gacs G, Fox AJ, Barnett HJM, et al:CT visualization of intracranial arterial thromboembolism. Stroke 14:756762, 1983

• 9) 高野健太郎, 峰松一夫, 山口武典ら:脳塞栓症及び血栓性主幹動脈閉塞症における急性期CT所見の差異-内頚動脈系脳梗塞に おける検討-. 臨床神経29:1370-1376, 1989

• 10) Okada Y, Yamaguchi T, Minematsu K, et al:Hemorrhagic transformation in cerebral embolism. Stroke 20:598-603, 1989
  pubmed

• 11) Bogousslavsky J, Regli F, Uske A, et al:Early spontaneous hematoma in cerebral infarct;Is primary cerebral hemorrhage overdiagnosed?Neurology 41:837-840, 1991
  pubmed

• 12) 米村公伸, 木村和美, 米満瑞恵ら:心原性脳塞栓症における頸動脈内の可動性病変の意義-脳塞栓症の診断を強く示唆する所 見として. 臨床神経 36:11251128, 1996

• 13) 原 靖幸, 寺崎修司, 米原敏郎ら:心原性脳塞栓症における頸部血管エコー検査の意義-内頸動脈に注目して-. 臨床神経 39:431-435, 1999

• 14) 池野幸一,橋本洋一郎, 内野 誠:経食道心エコーによる心内塞栓源の診断. カレントテラピー 17:1548-1555, 1999

• 15) Doi H, Misumi I, Kimura Y, et al:Early detection of left atrial thrombus in acute cardiogenic cerebral embolism by transesophageal echocardiography. J Cardiology 29:277-282, 1997
  pubmed

P.19 掲載の参考文献

• 1) Patel ML, Edelman RR, Warach S:Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 27:2321, 1996

• 2) Noguchi K, Ogawa T, Inugami A, et al:Acute subarachnoid hemorrhage;MR imaging with fluid-attenuated inversion recovery pulse sequences. Radiology 196:773, 1995
  pubmed

• 3) White PM, Teasdale EM, Wardlaw JM, et al:Intracranial aneurysms;CT angiography and MR angiography for detection prospective blinded comparison in a large patient cohort. Radiology 219:739-749, 2001

• 4) Kinoshita T, Okudera T, Tamura H, et al:Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI. Stroke 31:1646-1650, 2000
  pubmed

• 5) Oppenheim C, Stanescu R, Dormont D, et al:False-negative diffusion-weighted MR Findings in acute ischemic stroke. AJNR Am J Neuroradiol 21:1434-1440, 2000
  pubmed

• 6) Noguchi K, Ogawa T, Inugami A, et al:MRI of acute cerebral infarction;acomparison of FLAIR and T2-weighted fast spin-echo imaging. Neuroradiology 39:406, 1997

• 7) Yamada K, Wu O, Gonzalez G, et al:Magnetic resonance perfusion-weighted imaging of acute cerebral infarction. Effect of the calculation methods and underlying vasculopathy. Stroke 33:87-94, 2002

• 8) Koenig M, Klotz E, Luka B, et al:Perfusion CT of the brain;diagnostic approach for early detection of ischemic stroke. Radiology 209:85-93, 1998
  pubmed

• 9) Jones DK, Lythgoe D, Horsfield MA, et al:Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI. Stroke 30:393-397, 1999
  pubmed

• 10) Hirai T, Korogi Y, Ono K et al:Prospective evaluation of suspected stenoocclusive disease of the intracranial artery;combined MR angiography and CT angiography compared with digital subtraction angiography. AJNRAm J Neuroradiol 23:93-101, 2002

• 11) Huston J, Fain SB, Wald JT, et al l Carotid artery;elliptic centric contrast-enhanced MR angiography compared with conventional angiography 218:138-143, 2001

• 12) Aoki S, Yoshikawa T, Hori M, et al:Two-dimensional thick-slice MR digital subtraction angiography for assessment of cerebrovascular occlusive disease. Eur Radiol 10:18581864, 2000

• 13) Ogawa T, Yoshida Y, Okudera T, et al:Secondary thalamic degeneration after cerebral infarction in the middle cerebral artery distribution;evaluation with MR imaging. Radiology 204:255-262, 1997
  pubmed

• 14) Castillo M, Mukherji SK:Early abnormalities related to post-infarction wallerian degeneration;evaluation with MR diffusion-weighted imaging. J Comput Assist Tomogr 23:1004-1007, 1999

P.26 掲載の参考文献

• 1) Righetti E, Celani MG, Cantisani T, et al l Glycerol for acute stroke (Cochrane Review) . In;The Cochrane Library. Issue 3. Oxford:Update Software, 2001

• 2) Bereczki D:Cochrane report;asystematic review of mannitol therapy for acute ischemic stroke and cerebral parenchy, mal hemorrhage. Stroke 31:2719-2722, 2000

• 3) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plaminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995

• 4) Furlan A, Higashida R, Wechsler L, et al:Intra-arterial prourokinase for acute ischemic stroke. JAMA 2003-2011, 1999
  pubmed

• 5) International Stroke Trial Collaborative Group:The International Stroke Trial (IST) ;a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,345 patients with acute ischemic stroke. Lancet 349:1569-1581, 1997

• 6) Chamorro A:Immediate anticoagulation in acute focal ischemia revisited;gathering the evidence. Stroke 32:577-578, 2001
  pubmed

• 7) Cerebral Embolism Task Force:Cerebral brain embolism. Arch Neurol 43:71-84, 1986.
  pubmed

• 8) Cerebral Embolism Task Force:Cerebral brain embolism. The second report of the cerebral embolism task force. Arch Neurol 46:727-743, 1989
  pubmed

• 9) Swanson RA:Intravenous heparin for acute stroke. What can we learn from the materials? Neurology 52:17461750, 1999

• 10) Kay R, Wong KS, Ling Y, et al:Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Eng J Med 333:1588-1593, 1995

• 11) Hommel M for The FISS bis Investigators Group:Fraxiparine in ischemic stroke study (FISS bis) . Cerebrovasc Dis 8 (Suppl 4):19, 1998

• 12) The Publication Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators:Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke. JAMA 279:1265-1272, 1998
  pubmed

• 13) 田崎義昭, 小林祥泰, 東儀英夫ら:脳血栓症急性期に対する抗トロンビン薬MD-805の臨床的有用性. プラセボを対照とした多施設二重盲検群間比較試験.医学のあゆみ 161:887-907, 1992

• 14) Gubitz G, Counsell C, Sandercock P, et al:Anticoagulants for acute ischaemic stroke. Cochrane Database Sys Rev 2000:2:CD 000024

• 15) 大友英一, 沓沢尚之, 小暮久也ら:脳血栓症急性期におけるOKY-046の効果-プラセボを対照とした多施設二重盲検試験-. 臨床医薬 7:353-388, 1991

• 16) CAST (Chinese Acute Stroke Trial) Collaborative Group:CAST;randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 349:1641-1649, 1997

• 17) Chen ZM, Sandercock P, Pan HC, et al:Indications for early aspirin use in acute ischemic stroke. A combined analysis of 40, 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 31:1240-1249, 2000
  pubmed

• 18) The Abciximab in Ischemic Stroke Investigators:Abciximab in acute ischemic stroke. A randomized, double-blind, placebocontrolled, dose-escalation study. Stroke 31:601-609, 2000
  pubmed

• 19) 松本昌泰, 堀正二:酸化ストレスと脳血管障害. 血圧 8:493-500, 2001
  Medical*Online

• 20) Birmingham K:Future of neuroprotective drugs in doubt. Nature Med 8:5, 2002
  pubmed

• 21) Abe K:Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury. J Cereb Blood Flow Metab 20:1393-1408, 2000
  pubmed

• 22) Li Y, Chopp M, Chen J, et al:Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cerb Blood Flow Metab 20:1311-1319, 2000

• 23) Chen J, Li Y, Wang L, et al:Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011, 2001

P.32 掲載の参考文献

• 1) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325:445-453, 1991

• 2) Bamett HJ, Taylor DW, Eliasziw M, et al:Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339:1415-1425, 1998

• 3) Ferguson GG, Eliasziw M, Bart HW, et al:The North American Symptomatic Carotid Endarterectomy Trial;surgical results in 1415 patients. Stroke 30:1751-1758, 1999

• 4) Paciaroni M, Eliasziw M, Kappelle LJ, et al:Medical complications associated with carotid endarterectomy. North American Symptomatic Carotid Endarterectomy Trial (NASCET) . Stroke 30:1759-1763, 1999
  pubmed

• 5) MRC European Carotid Surgery Trial:interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 337:1235-1243, 1991

• 6) Randomised trial of endarterectomy for recently symptomatic carotid stenosis:final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351:1379-1387, 1998
  pubmed

• 7) Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Jama 273:1421-1428, 1995
  pubmed

• 8) Halliday AW, Thomas D, Mansfield A:The A symptomatic Carotid Surgery Trial (ACST) . Rationale and design. Steering Committee. Eur J Vasc Surg 8:703-710, 1994

• 9) Rothwell PM, Slattery J, Warlow CP:A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 27:260-265, 1996
  pubmed

• 10) McCrory DC, Goldstein LB, Samsa GP, et al:Predicting complications of carotid dndarterectomy. Stroke 24:1285-1291, 1993
  pubmed

• 11) Rothwell PM, Slattery J, Warlow CP:A systematic comparison of the risks of stroke and death due to carotid endarterectomy for symptomatic and asymptomatic stenosis. Stroke 27:266-269, 1996
  pubmed

• 12) Pritz MB:Timing of carotid endarterectomy after stroke. Stroke 28:2563-2567, 1997
  pubmed

• 13) Kerber CW, Cromwell LD, Loehden OL:Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol 1:348-349, 1980
  pubmed

• 14) Theron J, Raymond J, Casasco A, et al:Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. AJNR Am J Neuroradiol 8:495-500, 1987
  pubmed

• 15) Kachel R:Results of Balloon angioplasty in the carotid arteries. J Endovasc Surg 3:22-30, 1996
  pubmed

• 16) Gaunt ME, Brown L, Hartshome T, et al:Unstable carotid plaques;preoperative identification and association with intraoperative embolisation detected by transcranial Doppler. Eur J Vasc Endovasc Surg 11:78-82, 1996

• 17) Phatouros CC, Higashida RT, Malek AM, et al:Carotid artery stent placement for atherosclerotic disease;rationale, technique, and current status. Radiology 217:26-41, 2000
  pubmed

• 18) Sundt TM Jr, Meyer FB, Piepgras DG, et al:Risk factors and operative results. In:Weber, editor. Sundt's occlusive cerebrovascular disease, pp241-247, Saunders Philadelphia, 1994

• 19) Teitelbaum GP, Lefkowitz MA, Giannotta SL:Carotid angioplasty and stenting in high-risk patients. Surg Neurol 50:300-311;discussion 311-312, 1998

• 20) Mathur A, Roubin GS, Iyer SS, et al:Predictors of stroke complicationg carotid artery stenting. Circulation 97:1239-1245, 1998

• 21) Mathur A, Roubin GS, Gomez CR, et al:Elective carotid artery stenting in the presence of contralateral occlusion. Am J Cardiol 81:1315-1317, 1998
  pubmed

• 22) AbuRahma AF, Jennings TG, Wulu JT, et al:Redo carotid endarterectomy versus primary carotid endarterectomy. Stroke 21:2787-2792, 2001

• 23) Waigand J, Gross CM, Uhlich F, et al:Elective stenting of carotid artery stenosis in patients with severe coronary artery disease. Eur Heart J 19:1365-1370, 1998

• 24) Malek AM, Higashida Rr, Phatouros CC, et al:Stent angioplasty for cervical carotid artery stenosis in high-risk symptomatic NASCET-ineligible patients. Stroke 32:3029-3033, 2000

• 25) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 131:1191-1200, 1985

• 26) Ishikawa T, Houkin K, Abe H, et al:Cerebral haemodynamics and long-term prognosis after extracranial-intracranial bypass surgery. J Neurol Neurosurg Phychiatry 59:625-628, 1995

• 27) Powers WJ, Tempel LW, Grubb RL Jr:Influence of cerebral hemodynamics on stroke risk:one-year follow-up 30 medically treated patients. Ann Neurol 25:325-330, 1989
  pubmed

• 28) Kleiser B, Widder B:Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke 23:171-174, 1992
  pubmed

• 29) Yonas H, Smith HA, Durham SR, et al:Increased stroke risk predicted by compromised cerebral blood fiow reactivity. J Neurosurg 79:483-489, 1993

• 30) Yamauchi H, Fukuyama H, nagahama Y, et al:Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 61:18-25, 1996

• 31) Widder B, Kleiser B, Krapf H:Course of cerebrovascular reactivity in patients with carotid artery occlusions. Stroke 25:1963-1967, 1994
  pubmed

P.39 掲載の参考文献

• 1) Aoyagi N, Hayakawa I:Study on early re-rupture of intracranial aneurysms. Acta Neurochir 138:12-18, 1996

• 2) Mayberg MR, Batjer HH, Dacey R, et al:Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315-2328, 1994
  pubmed

• 3) Hadeishi H, Mizuno M, Suzuki A, et al:Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo) 30:317-323, 1990
  pubmed

• 4) Origitano TC, Wascher TM, Reichman OH, et al:Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (triple-H therapy) after subarachnoid hemorrhage. Neurosurg 27:729-740, 1990

• 5) Tokiyoshi K, Ohnishi T, Nii Y:Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 36:112-118, 1991
  pubmed

• 6) Shibuya M, Suzuki Y, Sugita K, et al:Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571-577, 1992

• 7) Guglielmi G, Vinuela F, Dion J, et al:Electrothrombosis of saccular aneurysms via endovascular approach. Part 2:Preliminary clinical experience. J Neurosurg 75:8-14, 1991
  pubmed

• 8) 金谷春之, 湯川英機, 神野哲夫ら:高血圧性脳出血における新しいNeurological gradingおよびCTによる血腫分類とその予後 について. 高血圧性脳出血の外科III, pp265-270, にゅーろん社,東京, 1978

• 9) 金谷春之:高血圧性脳出血の治療の現況-全国調査の成績より-. 脳卒中 12:509-524, 1990

• 10) Broderick JP, Adams HP, Barsan W Jr, et al:Guidelines for the management of spontaneous intracerebral hemorrhage. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 30:905-915, 1999

• 11) 鈴木明文,長田 乾, 川村伸悟ら:高血圧性脳出血急性期管理における統一した指針に基づくチーム医療の効果. 脳卒中 22:611-615, 2000
  Medical*Online

• 12) 鈴木明文, 瀧澤克己, 安井信之:高血圧性脳出血の治療. 図説脳神経外科New Approach 8脳血管障害 (高倉公朋, 斎藤 勇, 佐藤 潔編), pp176-181, メジカルビュー社, 東京, 1999

• 13) Takizawa K, Suzuki A, Nagata K, et al:Blood Pressure control in acute stages of hypertensive intracerebral hemorrhage-to prevent growth of hematoma-. Brain Hemorrhage '99 (edited by Yasui N), pp11-18, NEURON Publishing, Tokyo, 2002

• 14) Major Ongoing Stroke Trials:Surgical trial in intracerebral hemorrnage (STICH) . Stroke 30:490, 1999

P.45 掲載の参考文献

• 1) Millikan CH, et al:Rehabilitation from stroke. In:Stroke, pp205-220, Lea&Febiger, Philadelphia, 1987

• 2) Garrison SJ:脳卒中早期リハのリスク管理. The present status of stroke rehabilitation in the United States of America. 臨床リハ 5:353-358, 1996

• 3) 石神重信:脳卒中急性期のアプローチ. 早期リハはなぜ必要か. 臨床リハ 1:10-11, 1992

• 4) 藤本幹雄, 高橋紳一, 石神重信:肺塞栓を合併した左被殻出血のリハビリテーション症例報告. リハ医学 37:471-474, 2000

• 5) 大川嗣雄, 石神重信:脳卒中急性期リハは是か非か. リハ医学 29:501-516, 1992

• 6) 山口武典:脳卒中早期治療のリスク管理. 理・作・療法 20:85-88, 1986

• 7) 藤島正敏:高血圧と脳血管障害. 日本内科学会雑誌81:155-161, 1992

• 8) Adams HP Jr, Brott TG, Crowell RM, et al:Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:1901-1914, 1994
  pubmed

• 9) 井上 剛, 井林雪郎:血圧管理をどうするか. 別冊:医学のあゆみ;脳梗塞超急性期-Brain attack時代の診断と治療 (成冨博章 編), pp76-80, 医歯薬出版, 東京, 1991

• 10) 中村 昭:脳卒中リハビリテーションにおける合併症のマネージメント. 心疾患. 総合リハ 21:1027-1031, 1993

• 11) Caplan LR, Sergay S:Positional cerebral ischemia. J Neurol Neurosurg Psychiatry 39:385391, 1976

• 12) 石神重信:急性期リハビリテーションと予後. リハ医学 33:605-608, 1996

P.49 掲載の参考文献

• 1) The International Study of Unruptured Intracranial Aneurysm Investigators:Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Eng J Med 339:17251733, 1998

• 2) Juvela S, Porras M, Poussa K:Natural history of unruptured intracranial aneuryms;probability of and risk factors for aneurysm rupture. J Neurosurg 93:379-387, 2000

• 3) Juvela S, Poussa K, Porras M:Factors affecting formation and growth of intracranial aneurysms;a long term follow-up study. Stroke 32:485-491, 2001
  pubmed

• 4) 長嶺義秀, 冨永悌二, 清水宏明ら:無症候性脳動脈瘤の自然経過と治療方針. 神経研究の進歩 45:468-477, 2001

• 5) Raaymakers TWM, Rinkel GJE, Limburg M, et al:Mortality and morbidity of surgery for unruptured intracranial aneurysms. A meta-analysis. Stroke 29:1531-1538, 1998

• 6) Rinkel GJE, Djibuti M, Algra A, et al:Prevalence and risk of rupture of intracranial aneurysms. A systemic review. Stroke 29:251-256, 1998

• 7) Ujiie H, Sato K, Onda H, et al:Clinical analysis of incidentally discovered unruptured aneurysms. Stroke 24:1850-1856, 1993
  pubmed

• 8) Yoshimoto T, Mizio K:Importance of management of unruptured cerebral aneurysms. Surg Neurol 47:522-526, 1997

• 9) 吉本高志:無症候性脳血管病変の予後と対策に関する研究 (菊池晴彦編), 平成7年度厚生省循環器病研究委託費による研究報告集, pp98-99, 1997

• 10) Weir B:Unruptured intracranial aneurysms;a review. J Neurosurg 96:3-42, 2002
  pubmed

• 11) Weir B, Disney L, Karrison T:Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients. J Neurosurg 96:64-70, 2002
  pubmed

• 12) Winn HR, Jane JA, Taylor J, et al:Prevalence of asymptomatic incidental aneurysm;review of 468 arteriograms. J Neurosurg 96:43-49, 2002

P.56 掲載の参考文献

• 1) Antiplatelet Trialists:Collaboration:Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308:81-106, 1994

• 2) Antithrombotic Trialists' Collaboration:Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocaridial infarction, and stroke in high risk patients. Br Med J 324:71-86, 2002

• 3) Hankey GJ, Sudlow CLM, Dunbabin D, et al:Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 31:1779-1784, 2000
  pubmed

• 4) Uchiyama S, Yamazaki M, Maruyama S, et al:Shear-induced platelet aggregation in patients with cerebral ischemia. Stroke 25:1547-1551, 1994
  pubmed

• 5) Diener HC, Cunha L, Forbes C, et al:European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143:1-13, 1996
  pubmed

• 6) ESPS Group:European Stroke Prevention Study. Stroke 21:1122-1130, 1990

• 7) Uchiyama S, Nagayama T, Sone R, et al:Combination therapy With low-dose aspirin and ticlopidine in cerebral ischemia. Stroke 20:1643-1647, 1989
  pubmed

• 8) Yamazaki M, Uchiyama S, Iwata M:Measurement of platelet fibrinogen binding and P-selectin expression in patients with ischemic cerebrovascular disease. Thromb Res 104:197-205, 2001
  pubmed

• 9) Gotoh F, Tohgi H, Hirai S, et al:Cilostazol Stroke Prevention Study:aplacebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 9:147-157, 2000

• 10) Hart RG, Benavente O, McBride R, et al:Antithrombotic therapy to prevent stroke in patients with atrial fibrillation:a metaanalysis. Ann Intern Med 131:492-501, 1999
  pubmed

• 11) Atrial Fibrillation Investigators:Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation:analysis of pooled data from five randomized clinical trials. Arch Intern Med 154:1949-1957, 1994

• 12) Hart RG, Sherman DG, Easton JD, et al:Prevention of stroke in patients With nonvalvular atrial fibrillation. Neurology 51:674-681, 1998
  pubmed

• 13) Gorelick PB, Sacco RL, Smith DB, et al:Prevention of a first stroke. A review of guidelines and a multidiciplinary consensus statement from the National Stroke Association. JAMA 281:1112-1120, 1999

• 14) Fuster V, Ryden LE, Asinger RW, et al:ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation:executive summary. Circulation 104:2118-2150, 2001
  pubmed

• 15) Uchiyama S:Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation. Intern Med 40:11661167, 2001

• 16) Yasaka M, Minematsu K, Yamaguchi T:Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40:1183-1188, 2001
  pubmed

• 17) Yamaguchi T for Japanese Non Vavular Atrial Fibrillation-Embolism Secondary Prevention Study Group:Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation:multicenter, prospective, randomized trial. Stroke 31:817-821, 2000

• 18) 堀 正二, 石川欽司, 内山真一郎ら:本邦における心房細動患者の脳梗塞と抗血栓療法の実態についての調査研究. Jpn Circulation J 64 (Suppl III):993-1005, 2000

• 19) Gustafsson D, Antonsson T, Bylund R, et al:Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes. Thromb Haemost 79:110-118, 1998
  pubmed

• 20) Wolf PA, Clagett P, Easton JD, et al:Preventing ischemic stroke in patients with prior stroke and transient ischemic attack:a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30:1991-1994, 1999

• 21) Mohr JP, Thompson JLP, Lazar RM, et al for the Warfarin-Aspirin Recurrent Stroke Study Group:A comparison of warfarin and aspirin for prevention of recurrent ischemic stroke. N Engl J Med 345:1444-1451, 2001

• 22) Quinn MJ, Fizgerald DJ:Ticlodine and clopidogrel. Circulation 100:1667-1672, 1999

• 23) 内山真一郎:チクロピジン.クロピドグレル. 特集抗血小板薬の選択. 血栓と循環 6:15-20, 1998

• 24) Hollopeter G, Jantzen H-M, Vinsent D, et al:Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207, 2001

• 25) Coller BS:Anti-GPIIb/IIIa drugs:current strategies and future directions. Thromb Haemost 86:427-443, 2001
  pubmed

• 26) The Abciximab in Ischemic Stroke Investigators:Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dos-escalation study. Stroke 31:601-609, 2000

• 27) Adams H, Hacke W for the AbESTT Investigators:Abciximab in emergent stroke treatment trial (AbESTT) . Stroke 31:2864-2865, 2000

P.62 掲載の参考文献

• 1) Eastern Stroke and Coronary Heart Disease Collaborative Research Group:Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352:1801-1807, 1998

• 2) Pahor M, Pasty BM, Alderman MH, et al:Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies:a meta-analysis of randomized controlled trials. Lancet 356:1949-1959, 2000

• 3) Hansson L, Hedner T, Lund-Johansen P, et al:Randomised trial of effects of calcium antagonists compared with diuretics and betablockers on cardiovascular morbidity and mortality in hypertension:the Nordic Diltiazem (NORDIL) study. Lancet 356:359-365, 2000
  pubmed

• 4) Su TC, Jeng JS, Chien KL, et al:Hypertension status is the major detarminant of carotid atherosclerosis. A community-based studyin Taiwan. Stroke 32:22652271, 2001

• 5) 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン2000年版, 日本高血圧学会, 東京, 2000

• 6) PROGRESS Collaborator Group:Randomized trial of a perindopril based blood-pressure-lowering regimen among 6105 individual with previous stroke or transient ischemic attack. Lancet 358:1033-1101, 2001

• 7) Kario K, Pickering TG, Matsuo T, et al:Stroke prognosis and abnormal noctunal blood pressure falls in older hypertensives. Hypertension 38:852-857, 2001

P.68 掲載の参考文献

• 1) Brainin M:Overview of stroke data banks. Neuroepidemiology 13:250-258, 1994
  pubmed

• 2) Rothrock JF, Lyden PD, Brody ML, et al:An analysis of ischemic stroke in an urban southern California population. The University of California, San Diego, Stroke Data Bank. Arch Intern Med 153:619-624, 1993

• 3) Henriques IL, Bogousslavsky J:Value of stroke data banks for the analysis of clinical syndromes. Neuroepidemiology 13:296-300, 1994
  pubmed

• 4) Sacco RL:Interactions between stroke data banks and clinical trials. Neuroepidemiology 13:275-282, 1994
  pubmed

• 5) Brainin M:Research possibilities of stroke data banks. Nervenarzt 68:116121, 1997

• 6) Moulin T, Tatu L, Vuillier F, et al:Role of a stroke data bank in evaluating cerebral infarction subtypes;patterns and outcome of 1,776 consecutive patients from the Besancon stroke registry. Cerebrovasc Dis 10:261-271, 2000
  pubmed

• 7) 山口武典:脳梗塞急性期医療の実態に関する研究. 健康科学総合研究事業平成12年度研究報告書, 2001

• 8) 小林祥泰:脳卒中急性期患者データベースの構築に関する研究. 健康科学総合研究事業平成12年度研究報告書, 2001

• 9) 小林祥泰:脳卒中急性期患者データベースの構築に関する研究. 健康科学総合研究事業平成13年度研究報告書, 2002

• 10) 山口啓二, 堀 進悟ら:脳梗塞超急性期血栓溶解療法の需要. 日本救急医学会雑誌11:533, 2000 (抄録)

P.72 掲載の参考文献

• 1) 水野 肇:インフォームド.コンセント, 中公新書 958, 中央公論社, 東京, 1990

• 2) 浅井 篤, 服部健司, 大西基喜ら:医療倫理, pp57-71, 勁草書房, 東京, 2002

• 3) 柳田邦夫編, 厚生省健康政策局総務課監修:元気が出るインフォームド.コンセント, pp2-15, 中央法規, 東京, 1996

• 4) Wellwood I, Dennis MS, Warlow CP:Perceptions and knowledge of stroke among surviving patients with stroke and their carers. Age and Ageing 23:293-298, 1994
  pubmed

• 5) Wellwood I, Dennis M, Warlow CP:Patients:and carers:satisfaction with acute stroke management. Age and Ageing 24:519-524, 1995

• 6) 中山博文:日本脳卒中協会の現状と課題. Pharma Medica 19:99-108, 2001
  Medical*Online

• 7) 大野ゆう子:脳卒中Q&A:退院後に生活するう上で大切なことは何ですか?, 毎日ライフ 30:80-83, 1999

• 8) Hanger HC, Mulley GP:Questions people ask about stroke. Stroke 24:536538, 1993

• 9) Mazur DJ, Hickam DH:Patients:preferences for risk disclosure and role in decision making for invasive medical procedures. J Gen Intern Med 12:114-117, 1997
  pubmed

• 10) Ciccone A, Sterzi R, Crespi V, et al:Thrombolysis for acute ischemic stroke;the patient:s point of view. Cerebrovasc Dis 12:335-340, 2001
  pubmed

• 11) Han B, Haley WE:Family caregiving for patients with stroke. Review and analysis. Stroke 30:1478-1485, 1999
  pubmed

• 12) 中山博文, 辻本朋美:一般市民の脳卒中に関する知識. 診断と治療 89:1929-1932, 2001
  Medical*Online

• 13) 中山博文:Stroke unitは脳卒中患者の予後を改善するのか. EBMジャーナル 2:500-504, 2001

• 14) 吉田 聡, 三上八郎:セコンド.オピニオン治療 (増刊号) 83:443-448, 2001

• 15) 中山博文, 橋本洋一郎:脳卒中急性期医療の意義 (千野直一, 安藤徳彦他編), 脳卒中のリハビリテーション, 金原出版株式会社, 東京, 2001

• 16) 在宅ケアを支える診療所全国ネットワーク編, 退院後の脳卒中患者支援ガイド, 大阪, 1997

• 17) 山口武典, 中山博文企画:特集 脳卒中の再発予防とリハビリテーション, 毎日ライフ 1:12-119, 2002

疾患編

P.81 掲載の参考文献

• 1) Fisher CM:Lacunar strokes and infarcts;a review. Neurology 32:871-876, 1982
  pubmed

• 2) 磯野理, 平山惠造:手口症候群cheiro-oral syndrome, 日本臨牀 (増刊号) 「CT, MRI時代の脳卒中学」下巻, pp537-543 , 日本臨牀社, 大阪,1993

• 3) Mori E, Tabuchi M, Yamadori A:Lacunar syndrome due to intracerebral hemorrhage. Stroke 16:454-459, 1985
  pubmed

• 4) 矢坂正弘:脳卒中病型の鑑別診断 (出血と梗塞) . 脳卒中診療ハンドブック (峰松一夫編), pp185-186, 中外医学社, 東京, 1998

P.86 掲載の参考文献

• 1) Astrup J, Siesjo DK, Symon L:Thresholds in cerebral ischemia-The ischemic penumbra. Stroke 12:723-725, 1981

• 2) Mineatsu K, Yamaguchi T, Omae T:Spectacular shrinking deficit:a rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 42:157-162, 1992

• 3) National Institute of Neurological Disorder and Stroke early rt-PA Stroke Study Group;tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995

• 4) The European Cooperative Acute Stroke Study (ECASS):Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 274:1017-1025, 1995
  pubmed

• 5) Okada Y, Yamaguchi T, Minematsu K, et al:Hemorrhagic transformation in cerebral embolism. Stroke 20:598-603, 1989
  pubmed

P.91 掲載の参考文献

• 1) 岡田和悟:t-PAによる脳梗塞の線溶療法. 臨床医26:2373-2377, 2000

• 2) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333:1581-1587, 1995

• 3) Adams HP, Brott TG, Furlan AJ, et al:Guidelines for acute stroke;a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 27:1711-1718, 1996

• 4) Albers GW, Bates VE, Clark WM, et al:Intravenous tissue-type plasminogen activator for treatment of acute stroke:the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 283:1145-1150, 2000
  pubmed

P.95 掲載の参考文献

• 1) International Stroke Trial Collaborative Group. The International Stroke Trial (IST):A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19345 patients with acute ischemic stroke. Lancet 349:1569-1581, 1997

• 2) CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST:Randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischemic stroke. Lancet 349:1641-1649, 1997

P.103 掲載の参考文献

• 1) Fishe CM:The herald hemiparesis of basilar artery occlusion. Arch Neurol 45:1301-1303, 1988

• 2) 三輪英人, 平沢基之, 吉野英夫ら:片麻痺で発症し重症化した脳底動脈血栓症-Herald hemiparesisの2例-. 脳と神経 44:49-52, 1992

• 3) Montaner J, Molina C, Nvarez-Sabin J, et al l Herald hemiparesis of basilar artery occlusion:early recognition by transcranial Doppler ultrasound. Eur J Neurol 7:91-93, 2000

P.108 掲載の参考文献

• 1) Heilman KM, Watson RT, Valenstein E:Neglect and related disorders:Clinical Neuropsychology (Eds, Heilman KM, Valenstein E), 3rd ed, pp279-336, 0xford University Press, New York, 1993

• 2) 石合純夫:BIT行動性無視検査日本版. 新興医学出版社, 1999

P.118 掲載の参考文献

• 1) Fisher CM:Observations of the fundus oculi in transient monocular blindness. Neurology 9:333-347, 1959
  pubmed

• 2) The Amaurosis Fugax Study Group:Current management of amaurosis fugax. Stroke 21:201-208, 1990

• 3) Muller M, Wessel K, Mehdom E, et al:Carotid artery disease in vascular ocular syndromes. J Clin Neuro-ophthalmol 13:175-180, 1993

• 4) Bruno A, Corbett JJ, Biller J, et al:Transient monocular visual loss patterns and associated vascular abnormalities. Stroke 21:34-39, 1990
  pubmed

• 5) Hollenhorst RW:Significance of bright plaques in the retinal arterioles. JAMA 178:123-129, 1961

• 6) 木村和美, 橋本洋一郎, 古川明子ら:神経超音波検査-頭蓋内外血管の評価. 現代医療26:1152-1161, 1994

• 7) 寺崎修司, 橋本洋一郎,米原敏郎:神経超音波検査. 脳梗塞の診断と治療 (内野 誠, 橋本洋一郎編), pp223-233, 診療新社, 大阪, 1999

• 8) Tippin J, Corbett JJ, Kerber RE, et al:Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol 26:69-77, 1989

• 9) 大野尚登, 村田恭啓, 木村和美ら:一過性黒内障を繰り返した抗りん脂質抗体症候群の2例. 臨眼50:1795-1797, 1996

• 10) Yamaguchi S, Sugo T, Hashimoto Y, et al:Fibrinogen Kumamoto with an Aα Arg-19 to Gly substitution has reduced affinity for thrombin;possible relevance to thrombosis. 血栓止血誌 8:382-392, 1997

• 11) 佐々木康人, 上山秀嗣, 橋本洋一郎ら:進行型脳梗塞を呈した家族性アンチトロンビンIII異常症. 臨床神経 29:450-455, 1989

• 12) Ueyama H, Hashimoto Y, Uchino M, et al:progressing ischemic stroke in a homozygous variant of antithrombin III (AT-III) . Stroke 20:815-818, 1989

• 13) North American Symptomatic Carotid Endarterectomy Trial Collaborators;Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325:445453, 1991

• 14) European Carotid Surgery Trialist:Collaborative Group:MRC European Carotid Surgery Trialist' interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 337:1235-1243, 1991

• 15) Weber J, Remorda L, Mattle HP, et al:Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 29:2076-2079, 1998

• 16) Per Brodal:The visual system. In;The central nervous system, second ed, pp245-280, Oxford, New York, 1998

• 17) 森安秀樹, 矢坂正弘, 峰松一夫ら:後大脳動脈皮質枝領域梗塞の病因の検討. 臨床神経 35:344-351, 1995

• 18) 寺崎修司, 粕谷潤二, 橋本洋一郎ら:外側膝状体で特異な形状の暗点を呈した脳塞栓症の1例. 臨床神経 39:845-848, 1999

• 19) Wada K, Kimura K, Minematsu K, et al:Incongruous homonymous hemianopic scotoma. J Neurol Sci 163:179-182, 1999
  pubmed

P.124 掲載の参考文献

• 1) Fisher CM, Karnes WE, Kubik CS:Lateral medullary infarction;the pattern of vascular occlusion. J Neuropath Exp Neurol 29:323-379, 1961

• 2) Ad hoc Committee (NIH, NINDS):Classification of cerebrovascular diseases III. Stroke 21:637-676, 1990

• 3) Wederkin L, Juhler M:The course of transient ischemic attacks. Neurology 38:677-680, 1988

• 4) Levy DE:How transient are transient ischemic attacks. Neurology 38:674-677, 1988
  pubmed

• 5) 永山正雄, 篠原幸人:若年発症虚血性脳血管障害の原因疾患と危険因子. 循環科学 15:984989, 1995

• 6) Campbell JK, Sakai F:Migraine:diagnosis and differential diagnosis. In;Olesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches, pp271-281, Raven Press, New York, 1993

• 7) Schievink WI:Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 344:898906, 2001

• 8) 福内靖男:TIAの概念の変遷と診断基準-NINDS, NIH分類 (1990) を中心に-. 日本臨牀 51 (増刊):915-921, 1993

• 9) Mead GE, Wardlaw JM, Lewis SC, et al:Can simple clinical features be used to identify patients with severe carotid stenosis on Doppler ultrasound? J Neurol Neurosurg Psychiatry 66:16-19, 1999
  pubmed

P.128 掲載の参考文献

• 1) Kleinman Y, Kom-Lubetzki I, Eliashiv S, et al:High frequency of hemorrhagic strokes in Jarusalem during the Persian Gulf War. Neurology 42:2225-2226, 1992

• 2) Lammie GA, Lindley R, Keir S, et al:Stress-related primary intracerebral hemorrhage. Autopsy clues to underlying mechanism. Stroke 31:14261428, 2000

• 3) 北園孝成, 藤島正敏:ストレスと脳血管障害. 循環器科42:406-410, 1997

• 4) House A, Dennis M, Mogridge L, et al:Life events and difficulties preceding stroke. J Neurol Neurosurg Psychiatry 53:1024-1028, 1990
  pubmed

• 5) Harmsen P, Rosengren A, Tsipogianni A, et al:Risk factors for stroke in middle-aged men in Goteborg, Sweden. Stroke 21:223-229, 1990
  pubmed

• 6) Kelly-Hayes M, Wolf PA, Kase CS, et al:Temporal patterns of stroke onset. The Framingham Study. Stroke 26:1343-1347, 1995
  pubmed

• 7) Haapanieimi H, Hillbom M, Juvel S:Weekend and holiday increase in the onset of ischemic stroke in young women. Stoke 27:1023-1027, 1996

• 8) 山口武典:平成12年度厚生科学研究費補助金 健康科学総合研究事業研究報告書. 脳梗塞急性期医療の実態に関する研究, p8

• 9) Casetta I, Granieri E, Fallica E, et al:Patient demographic and clinical features and circadian variation in onset of ischemic stroke. Arch Neurol 59:4853, 2002

• 10) Klatsky AL, Armstrong MA, Friedman GD:Alcohol use and subsequent cerebrovascular disease hospitalizations. Storke 20:741-746, 1989

• 11) Hillbom M, Haapaniemi H, Juvela S, et al:Recent alcohol consumption, cigarette smoking, and cerebral infarction in young adults. Stroke 26:40-45, 1995
  pubmed

• 12) Rothwell DM, Bondy SJ, Williams JI:Chiropractic manipulation and stroke. A population-based case-control study. Stroke 32:105-1060, 2001

• 13) Macko RF, Ameriso SF, Barndt R, et al:Precipitants of brain infarction. Role of preceding infection/inflammation and recent psychological stress. Stroke 27:1999-2004, 1996
  pubmed

• 14) Gorelick PB:Stroke prevention therapy beyond antithrombotics;Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke 33:862-875, 2002
  pubmed

P.134 掲載の参考文献

• 1) Tomura U, Uemura K, Inugami A, et al:Early CT finding in cerebral infarction;obstruction of the lentiform nucleus. Radiology 18:463-467, 1988

• 2) von Kummer R, Notle PN, Schnittger H, et al:Detectability of cerebral hemispheric ischemic infarcts by CT within 6h of stroke. Neuroradiology 38:31.33, 1996

• 3) Rauch WA Bazan CIII, Larsson EM, et al:Hyperdense middle cerebral arteries identhied on CT as a false sigti of vascular occlusion. AJNR 14:669-673, 1993

• 4) Astrup J, Siesjo BK, Symon L:Thresholds in cerebral ischemia-The ischemic penumbra. Stroke 12:723-725, 1981
  pubmed

• 5) Jones TH, Morawetz RB, Crowell RM, et al:Threshold of focal cerebral ischemia in awake monkeys. J Neurosurg 54:773-782, 1981
  pubmed

• 6) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group:Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995

• 7) 中川原譲二, 瓢子敏夫, 片岡丈人ら:血栓溶解療法における画像診断 (SPECT/PET, CT/MRI) の役割. 脳と神経 52:873-882, 2000

• 8) Feeney DM, Baron JC:Diaschisis. Stroke 17:817-830, 1986
  pubmed

• 9) Hacke W, Schwab S, Hom M, et al:Malignant middle cerebral artery tenitory infarction;clinical course and prognostic signs. Arch Neurol 53:309-315, 1996

• 10) Wu O, Koroshetz WJ, Ostergaard L, et al:Predicting tissue outcome in acute human cerebral ischemia using combined diffusion and perfusion-weighted MR imaging. Stroke 32:933-942, 2001
  pubmed

P.139 掲載の参考文献

• 1) Handa N, Matsumoto M, Maeda H, et al:Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21 (11):1567-1572, 1990
  pubmed

• 2) Hougaku H, Matsumoto M, Kitagawa K, et al:Silent cerebral infarction as a form of hypertensive target organ damage in the brain. Hypertension 20 (6):816-820, 1992
  pubmed

• 3) Hougaku H, Matsumoto M, Handa N, et al:Asymptomatic carotid lesions and silent cerebral infarction. Stroke 25(3):566570, 1994

• 4) Hougaku H, Matsumoto M, Hashikawa K, et al:The role of brain imaging in the preoperative evaluation of carotid surgical patients. In Loftus C editor. Text book of carotid artery surgery, pp81-93, Thieme Publishers, New York, 1999

• 5) North American Symptomatic Carotid Endarterectomy Trial Collaborators:Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (7):445-453, 1991
  pubmed

• 6) Barnett HJ, Taylor DW, Eliasziw M, et al:Benefit of carotid endarterectomy in patients with symptomatic moderate or severestenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339 (20):1415-1425, 1998
  pubmed

• 7) Executive Committee for the A symptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (18):1421-1428, 1995

• 8) CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS):a randomised trial. Lancet 357 (9270):1729-1737, 2001

• 9) Hobson RW:2nd. Status of carotid angioplasty and stenting trials. J Vasc Surg 27 (4):791, 1998
  pubmed

P.144 掲載の参考文献

• 1) Shuttleworth EC, Morris CE:The transient global amnesia syndrome. A defect in the second stage of memory in man. Arch Neurol 15:515-520, 1966
  pubmed

• 2) Tulving E:How many memory systems are there? Am Psychologist 40:385-398, 1985

• 3) Fisher CM, Adams RD:Transient global amnesia. Trans. Am Neurol Asoc 83:143-146, 1958

• 4) Caplan LB:Transient global amnesia. "Handbook of Clinical Neurology 45:Clinical Neuropsychology" ed by Frederiks JAM, p205, Elsevier Science Publishers, Amsterdam, 1985

• 5) 篠原幸人:一過性全健の成因. 医学のあゆみ117:854-855, 1981

• 6) Meador KJ, Adams RJ, Flanigin HF:Transient global amnesia:criteria and classification. Neurology 36:441-442, 1986

• 7) Miller JW, Pertersen RC, Metter EJ, et al:Transient global amnesia. Clinical characteristics and prognosis. Neurology 37:733-737, 1987

• 8) 高橋若生, 篠原幸人:一過性全健忘症候群. Clin Neurosci 14:1186-1187, 1996

• 9) 高橋祥友:全生活史健忘の臨床的研究. 精神経誌 91:260-293, 1989

• 10) 吉井文均:視床と疾患. 画像診断-MRIを中心に. Clin Neurosci 18:928-933, 2000

• 11) 秋口一郎, 猪野正志, 亀山正邦:脳血管障害と健忘. 神経進歩 32:646-657, 1988

• 12) Castaigne P, Lhermitte F, Buge A, et al:Paramedian thalamic and midbrain infarcts;clinical and neuropathological study. Ann Neurol 10:127-148, 1981
  pubmed

P.150 掲載の参考文献

• 1) Li JS, Sexton DJ, Mick N, et al:Proposed modification to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633-638, 2000

P.156 掲載の参考文献

• 1) 井川房夫, 栗栖 薫, 有田和徳ら:超急性期脳梗塞における拡散強調画像の意義と読影の注意点-全国アンケート調査より-. 脳神経 61:515, 1999

• 2) Ikawa F, Kurisu K, Arita K, et al:Usefulness and limitation of diffusion weighted image and perfusion image by EPI in super acute ischemic stroke and brain tumor (Naruse S and Watari H, edt), Ultrafast Magnetic Resonance Imaging in Medicine, pp213-221, Amsterdam Netherland, Elsevier, 1999

• 3) Inagawa T:What are the actual incidence and mortality rates of subarachnoid hemorrhage. Surg Neurol 47:47-53, 1997
  pubmed

• 4) van der Wee N, Rinkel GJ, Hasan D, et al:Detection of subarachnoid haemorrhage on early CT:is lumbar puncture still needed after a negative scan?JNeurol Neurosurg Psychiatry 58:357-359, 1995
  pubmed

P.161 掲載の参考文献

• 1) 長谷川和夫監修:日本医師会雑誌臨時増刊号「老年期痴呆診療マニュアル」 (上田慶二, 大塚俊男, 平井俊策, 本間 昭編), p337, 日本医師会, 東京, 1995

• 2) 水野美邦編集:神経内科ハンドブック「鑑別診断と治療」, 第2版, p887, 医学書院, 東京, 2000

• 3) 石合純夫:高次機能障害, p229, 新興医学出版社, 東京, 1997

P.168 掲載の参考文献

• 1) Toyoda K, Ida M, Fukuda K:Fluid-attenuated inversion recovery intraarterial signal;an early sign of hyperacute cerebral ischemia. Am J Neuroradiol 22:1021-1029, 2001
  pubmed

• 2) Castillo M, Mukherji SK:Early abnormalities related to postinfarction Wallerian degeneration;evaluation with MR diffusion-weighted imaging. J Comput Assist Tomogr 23:1004-1007, 1999
  pubmed

• 3) Kang DW, Chu K, Yoon BW, et al:Diffusion-weighted imaging in Wallerian degeneration. J Neurol Sci 178:167-169, 2000
  pubmed

• 4) Tomura N, Uemura K, Inugami A, et al:Early CT finding in cerebral infarction;obscuration of the lentiform nucleus. Radiology 168:463-467, 1988
  pubmed

• 5) Truwit CL, Barkovich AJ, Gean-Marton A, et al:Loss of the insular ribbon;another early CT sign of acute middle cerebral artery infarction. Radiology 176:801-806, 1990
  pubmed

• 6) Kummer R, et al:Detectability of cerebral hemisphere ischemic infarcts by CT within 6 th of stroke. Neuroradiology 38:31-33, 1996

• 7) Tomsick T, Brott T, Barsan W, et al:Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. Am J Neuroradiol 17:79-85, 1996
  pubmed

• 8) Ducreux D, Oppenheim C, Yandamme X, et al:Diffusion-weightedimaging patterns of brain damage associated with cerebral venous thrombosis. Am J Neuroradiol 22:261-268, 2001

• 9) Forbes KP, Pipe JG, Heiserman JE:Evidence for cytotoxic edema in the pathogenesis of cerebral venous infarction. Am J Neuroradiol 22:450-455, 2001
  pubmed

P.175 掲載の参考文献

• 1) Handa N, Matsumoto M, Maeda H, et al:Ischemic stroke events and carotid atherosclerosis. Stroke 26:1781-1786, 1995
  pubmed

P.187 掲載の参考文献

• 1) Bokura H, Kobayashi S, Yamaguchi S:Discrimination of silent lacunar infarction from enlarged Virchow-Robin spaces on brain magnetic resonance imaging-clinicopathological study-.J Neurology 245:116-122, 1998

• 2) Shimada K, Kawamoto A, Matsubayashi K, et al:Silent cerebrovascular disease in the elderly:Correlation with ambulatoy pressure. Hypemsion 16:692-699, 1990
  pubmed

• 3) Kobayashi S, Okada K, Yamashita K:Incidence of silent lacunar lesion in normal adults and its relationship to cerebral blood flow and risk factors. Stroke 22:1379-1383, 1991

• 4) Shinkawa A Ueda K, Kiyohara Y, et al:Silent cerebral inflaction in a community-based autopsy series in Japan;The Hisayama study. Stroke 26:380-385, 1995

• 5) 篠原幸人:脳検診 (脳ドック) の意義と現状. 日内会誌 86:787-791, 1997

• 6) 小林祥泰:無症候性脳梗塞は脳卒中の危険因子といえるか. EBMジャーナル 2:326-331, 2001
  Medical*Online

P.193 掲載の参考文献

• 1) 高木 誠:心房細動による脳塞栓の診断と予後. 循環器Today 1:678-684, 1997

• 2) 内山真一郎:非弁膜症性心房細動患者の脳卒中予防における抗凝血薬と抗血小板薬の優劣. Clin Neurosci 20:182-185, 2002

• 3) Hart RG, Halperin JL:Atrial fibrillation and stroke. Concepts and controversies. Stroke 32:803-808, 2001
  pubmed

• 4) Minematsu K, Yamaguchi T, Omae T:Spectacular shrinking deficit:Rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 42:157-162, 1992

• 5) Cerebral Embolism Task Force:Cardiogenic brain embolism. Arch Neurol 43:71-84, 1986
  pubmed

• 6) Cerebral Embolism Task Force:Cardiogenic brain embolism. The second report of the cerebral embolism task force. Arch Neurol 46:727-743, 1989
  pubmed

• 7) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group:Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995

• 8) 山口武典:脳梗塞急性期医療の実態に関する研究. 平成12年度厚生科学研究費補助金, 健康科字総合研究事業研究報告書, 2001

• 9) European Atrial Fibrillation Trial Study Group:Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342:1255-1262, 1993
  pubmed

• 10) Adams HP:Emergent use of anticoagulation for treatment of patients with ischemic stroke. Stroke 33:856861, 2002

• 11) International Stroke Trial Collaborative Group:The International Stroke Trial (IST):a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569-1581, 1997
  pubmed

• 12) Toni D, Fiorelli M, Bastianello S, et al:Hemorrhagic transformation of brain infarct:Predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 46:341-345, 1996
  pubmed

• 13) Yatsu FM, Hart RG, Mohr JP, et al:Anticoagulation of embolic strokes of cardiac origin:An update. Neurology 38:314-316, 1988
  pubmed

• 14) Berge E, Abdeinoor M, Nakstad PH, et al:Low Molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:a double-blinded randomized study. Lancet 355:1205-1210, 2000

P.197 掲載の参考文献

• 1) Benson DF:Aphasia, Alexia, and Agraphia, Churchill Livingstone, New York, 1979

• 2) Benson DF, Ardila A:Aphasia-a clinical perspective, Oxford University Press, New York, 1996

• 3) 石合純夫:高次神経機能障害, 新興医学出版社, 東京, 1997

P.198 掲載の参考文献

• 1)Metter EJ:Motor speech production and assessment-neurologic perspective. in Speech and Language Evaluation in Neurology-Adult Disorders(ed,Darby JK,New York,Grune and Stratton,1995

• 2)本村 暁:構音障害に対する言語治療-現状と問題点-.神経治療学14:216-223,1997

P.203 掲載の参考文献

• 1) Hachinski VC, Lassen NA, Marshall J:Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet ii:207, 1974

• 2) Roman GC, Tatemichi TK, Erkinjuntti T, et al:Vascular dementia:diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250-260, 1993
  pubmed

P.207 掲載の参考文献

• 1) Barnett HJM, et al:Stroke. Pathophysiology, diagnosis and management. Churchill Livingstone, Philadelphia, 1998.

• 2) 千代豪昭:遺伝カウンセリング, 東京, 医学書院, 2000

• 3) 内野 誠ら:CADASIL. 本邦におけるCADASILならびに類似疾患の臨床解析. 臨床神経40:1247-1250, 2000

• 4) Dhalla NS, Temsah RM, Netticadan T:Role of oxidative stress in cardiovascular diseases. J Hypertens 18:655-673, 2000
  pubmed

P.213 掲載の参考文献

• 1) Adams RD, Vrictor M, Ropper AH:Principles of Neurology, ed 6, New York, McGraw-Hill, 1997

• 2) Geschwind N:Disorders of attention:a frontier in neuropsychology. Phil Trans R Soc Lond B298:173-185, 1982

• 3) Lipowski ZJ:Derilium (acute confusional states). JAMA 258:1789-1792, 1987

• 4) 森 悦朗:Confusional stateの神経心理.脳と精神の医学4:425-430, 1993

• 5) Mori E:Acute behavioral derangement:impairments of awareness, attention, emotion, and motivation:Cerebrovascular Disease:Pathophysiology, Diagnosis, and Management (Ginsberg M, Bogousslavsky J, eds), Chapter 79, Vol 2, pp1145-1148, Blackwell, Cambridge, 1998

• 6) Bogousslavsky J, Ferrazzini M, Regli F, et al:Manic delirium and frontal-like syndrome with paramedian infarction of the right thalamus. J Neurol Neurosurg Psychiatry 51:116-119, 1988

• 7) Mendez MF, Adams NL, Lewandowski KS:Neurobehavioral changes associated with caudate lesions. Neurology 39:349-354, 1989
  pubmed

• 8) Mesulam M-M, Waxman SG, Geshwind N, et al:Acute confusional atates with right middle cerebral infarction. J Neurol Neurosurg Psychiatry 39:84-89, 1976

• 9) Mori E, Yamadori A:Acute confusional state and acute agitated delirium. Occurrence after infarction in the right middle cerebral artery territory. Arch Neurol 44:1139-1143, 1987
  pubmed

• 10) Caplan LR, Kelly M, Kase CS, et al:Infarcts of the inferior division of the right middle cerebral artery:mirror image of Wernicke's aphasia. Neurology 36:1015-1020, 1986
  pubmed

• 11) Amyes EW, Nielsen JM:Clinicopathological study of vascular lesions of the anterior cingulate region. Bull Los Angeles Neurol Soc 20:112-130, 1955
  pubmed

• 12) Bogousslavsky J, Regli F:Anterior cerebral artery territory infarction in the Lausanne Stroke Registry. Clinical and etiologic patterns. Arch Neurol 47:144-150, 1990
  pubmed

• 13) Medina JL, Rubino FA, Ross A:Agitated delirium caused by infarction of the hippocampal formation and fusiform gyri:A case report. Neurology 24:1181-1183, 1974

• 14) Devinsky O, Bear D, Volpe BT:Confusional states following posterior cerebral artery infarction. Arch Neurol 45:160-163, 1988
  pubmed

• 15) Mullally WJ, Ronthal M, Huff K, et al:Chronic confusional state. N J Med 86:541-544, 1989
  pubmed

P.221 掲載の参考文献

• 1) Tsubokawa T, Katayama Y, Yamamoto T, et al:Chronic motor cortex stimulation in patients with thalamic pain. J Neurosurg 78:393-401, 1993

• 2) Yamamoto T, Katayama Y, Hirayama T, et al:Pharmacological classification of central post-stroke pain;comparison with the results of chronic motor cortex stimulation therapy. Pain 72:512, 1997

• 3) Katayama Y, Fukaya C, Yamamoto T:Poststroke pain control by chronic motor cortex stimulation;neurological characteristics predicting a favorable response. J Neurosurg 89:585591, 1998

P.225 掲載の参考文献

• 1) Chino N, Sonoda S, Domen K, et al:Stroke impairment assessment set (SIAS) a new evaluation instrument for stroke patients. リハ医学 31:119-125, 1994

• 2) Hachisuka K, Okazaki T, Ogata H:Self-rating Barthel index compatible with the original Barthel index and the Functional Independence Measure motor score. J UOEH 19;107-121, 1997

• 3) 蜂須賀研二:脳卒中急性期のリハビリテーション. Medicina 34:2388-2389, 1997

• 4) 山口武則, 寺井敏:脳卒中早期治療のリスク管理. 理・作・療法 20:85-88, 1986

• 5) Anderson TP:Management of completed stroke. J Okla State Med Assoc 63:403-411, 1970
  pubmed

• 6) Hachisuka K, Umezu U, Ogata H:Disuse muscle atrophy of lower limb in hemiplegic patients. Arch Phys Med Rehabil 78:13-18, 1997

• 7) 奈良聡一郎, 蜂須賀研二, 緒方 甫:廃用性筋萎縮の病態と予防. 日本医事新報3901:8-13, 1999

P.235 掲載の参考文献

• 1) King MA, Newton MR, Jackson GD, et al:Epileptology of the first-seizure presentation;aclinical, electroencephalographic, and magnetic resionance imaging study of 300 consecutive patients. Lancet 352:1007-1011, 1998

• 2) 平田 温:脳卒中とてんかん発作. 田川皓一, 藤井清孝編, 脳卒中治療学, pp228-231, 西村書店, 新潟, 1999

• 3) Bum J, Dennis M, Bamford J, et al:Epileptic seizures after a first stroke:the Oxfordshire community stroke project. Brit Med J 315:1582-1587, 1997

• 4) Mohr JP:A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345:1444-1451, 2001
  pubmed

P.243 掲載の参考文献

• 1) 金子芳洋.千野直一監修:摂食.嚥下リハビリテーション, 医歯薬出版, 東京, 1998

• 2) Leopold NA, Kagel MC:Swallowing, Ingestion and dysphagia:a reappraisal. Arch Phys Med Rehabil 64:371-373, 1983
  pubmed

• 3) 小椋 脩ら:嚥下障害の臨床-リハビリテーションの考え方と実際, 医歯薬出版, 東京, 1998

• 4) 田山二郎:摂食.嚥下のメカニズムと病態. 口獨医報46:7-16, 2001

• 5) 岡田澄子:摂食.嚥下障害のリハビリテーション. (1) 間接的嚥下訓練. 日獨医報46:40-45, 2001

• 6) 馬場 尊:摂食.嚥下訓練の実際. 臨床栄養 99:158-164, 2001
  Medical*Online

• 7) 平岡 崇, 石井雅之, 椿原彰夫:脳血管障害急性期. 総合リハ 28:415-421, 2000

• 8) 目谷浩通, 椿原彰夫:経口摂取を開始しよう, ブレインナーシング 17:89-96, 2001

• 9) 石井雅之:嚥下障害の病態.評価.治療体系. 日本摂食.嚥下リハビリテーション学会公認, 第1回中国四国摂食.嚥下技術 セミナー, 岡山, 1999

• 10) Whisnant JP, Basford JR, Bemstein EF, et al:Classification of cerebrovascular disease III. Stroke 211637-676, 1990

• 11) 塚本芳久:急性期嚥下障害へのアプローチ. 臨床リハ 4:721-724, 1995

• 12) 馬場 尊, 才藤栄一:摂食.嚥下障害の診断と評価. 日獨医報 46:17-25, 2001

• 13) 藤島一郎:脳血管障害慢性期. 総合リハ28:423-428, 2000

• 14) 小口和代,才藤栄一, 水野雅康ら:機能的嚥下障害スクリーニングテスト「反復唾液嚥下テスト」 (Repetitive Saliva Swallowing Test:RSST) の検討 (1) 正常値の検討. (2) 妥当性の検討. リハ医学 37:375-388, 2000

• 15) 大熊るり, 宮野佐年:摂食.嚥下障害のリハビリテーション (2) 直接的嚥下訓練. 日獨医報 46:46-53, 2001

• 16) Groher ME (藤島一郎鑑訳):嚥下障害-その病態とリハビリテーション. 第2版, 医歯薬出版, 東京, 1996

• 17) 里宇明元:嚥下リハビリテーションの問題点. 臨床リハ 8:689-696, 1999

P.247 掲載の参考文献

• 1) Hart RG, Sherman DG, Donald Easton J, et al:Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51:674681, 1998

• 2) Feinberg WM, Blackshear JL, Laupacis A, et al:Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intem Med 155:469-473, 1995

• 3) Wolf PA, Dawber TR, Thomas HE Jr, et al:Epidemiologic assessment of chronic atrial fibrillation and risk of stroke;the Framingham study. Neurology 28:973-977, 1978
  pubmed

• 4) Cerebral Embolic Task Force:Cardiogenic brain embolism. Arch Neurol 43:71-84, 1986
  pubmed

• 5) 内山真一郎:心房細動による血栓塞栓症とその予防. 内科89:5-11, 2002

• 6) Petersen P, Boysen G, Godtfredsen J, et al:Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation;the Copenhagen AFASAK study. Lancet 1:175-179, 1989
  pubmed

• 7) Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study:final results. Circulation 84:527-539, 1991

• 8) Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in nonrheumatic atrial fibrillation. N Engl J Med 323:1505-1511, 1990

• 9) Connolly SJ, Laupacis A, Gent M, et al, for the CAFA study coinvestigators:Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18:349-355, 1991

• 10) Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated With nonrheumatic atrial fibrillation. N Engl J Med 327:14061412, 1992

• 11) Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449-1457, 1994

• 12) Hart RG, Halperin JL:Atrial fibrillation and stroke:Concepts and controversies. Stroke 32:803-808, 2001
  pubmed

• 13) The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II. Echocardiagraphic features of patients at risk. Ann Intern Med 116:6-12, 1992

• 14) Laupacis A, Albers G, Dalen J, et al:Antithrombotic therapy in atrial fibrillation. Chest 108 (suppl):352S-359S, 1995

• 15) Stroke Prevention in Atrial Fibrillation Investigators:Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation;Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 348:633-638, 1996

• 16) 矢坂正弘:Warfarinの使い方と出血性合併症への対応. 内科89:83-87, 2002

• 17) Hylek EM, Skates SJ, Sheehan MA, et al:An analysis of the lowest intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 335:540-546, 1996
  pubmed

• 18) Yamaguchi T, for Japanese Nonvalvular Atrial Fibrilllation-Embolism Secondary Prevention Cooperative Study Group:Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation;a multicenter, prospective, randomized trial. Stroke 31:817-821, 2000

• 19) Yasaka, Minematsu K, Yamaguchi T:Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40:1183-1188, 2001
  pubmed

• 20) 内山伸治:非弁膜症性心房細動と抗凝固療法:Evidenceとclinical practice. 別冊.医学のあゆみ 脳血管障害-臨床と研究 の最前線 (東儀英夫編), pp164-168, 医歯薬出版, 東京, 2001

P.255 掲載の参考文献

• 1) 石田 肇:痛み, 東京,医学書院, 1997

• 2) 佐久間穣爾ら:Signe Brunnstrom片麻痺の運動療法, pp42-43 , 医歯薬出版, 東京, 1974

• 3) 最新医学辞典 第1版, p671, 医歯薬出版, 東京, 1987

• 4) 北村歳男ら:胸郭出口症候群とは. Journal of Clinical Rehabilitation, pp227-234, 1997

• 5) 竹下 満:胸郭症候群の診断. Journal of Clinical Rehabilitation, pp235-241, 1997

• 6) 整形外科学辞典初版, p40, 南江堂, 東京, 1994

• 7) 細田多穂, 柳澤 健, 編,理学療法ハンドブック第3版, pp454-455, 協同医書, 東京, 2000

• 8) 山本龍二ら:肩関節の外科 改訂第2版, pp290-293, 南江堂, 東京, 2000

• 9) 宗重 博, 戸田克広:反射性交感神経性ジストロフィー. 総合リハ 26:739-742, 1998